GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,049,000 | -6.4% | 75,120 | -0.6% | 0.58% | -10.8% |
| Q2 2017 | $3,259,000 | +4.7% | 75,577 | +2.4% | 0.66% | +2.7% |
| Q1 2017 | $3,112,000 | +13.5% | 73,823 | +3.7% | 0.64% | +11.7% |
| Q4 2016 | $2,741,000 | -12.5% | 71,214 | -2.0% | 0.57% | -17.8% |
| Q3 2016 | $3,134,000 | +18.5% | 72,654 | +19.1% | 0.70% | +12.8% |
| Q2 2016 | $2,645,000 | +28.9% | 61,013 | +20.5% | 0.62% | +19.8% |
| Q1 2016 | $2,052,000 | +1.6% | 50,625 | +1.1% | 0.51% | +2.0% |
| Q4 2015 | $2,020,000 | +52.8% | 50,077 | +45.7% | 0.50% | +41.2% |
| Q3 2015 | $1,322,000 | -4.0% | 34,369 | +3.9% | 0.36% | +1.7% |
| Q2 2015 | $1,377,000 | -5.4% | 33,070 | +4.8% | 0.35% | -5.4% |
| Q1 2015 | $1,456,000 | +36.8% | 31,548 | +26.7% | 0.37% | +34.4% |
| Q4 2014 | $1,064,000 | +56.0% | 24,903 | +67.8% | 0.28% | +52.5% |
| Q3 2014 | $682,000 | – | 14,844 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |